Ligand Dependent and Independent Activation of the Androgen Receptor

  • Gloria R. Mora
  • Donald J. Tindall
Part of the Contemporary Cancer Research book series (CCR)


Androgens play a pivotal role in the embryonic development, growth, and function of many tissues within male species. The cells of these tissues are influenced by androgens through the binding and resultant conformational changes in the androgen receptor (AR). The importance of the role played by ARs in the life of androgen dependent tissues is evidenced in the genetic diseases that produce alterations in the AR, resulting in alterations in the male phenotype. Most of the available knowledge regarding the function of androgens and the role of AR has been obtained from studies of the prostate gland. These studies have elucidated the importance of androgens in the maintenance of homeostasis. The prostate provides a physiologic tissue model of AR action. The study of prostate cancer also provides a pathophysiologic model for the investigation of androgens and AR. Androgen ablation therapies in prostate cancer take advantage of the continued requirement of the androgen-AR relationship in the immortalized tumor cells. Unfortunately, these therapies often fail with time, and the disease progresses to an androgen refractory and/or androgen independent stage. Recent studies have begun to pull back the veil regarding the pathophysiology of these refractory cells and the role of AR in their growth.


Androgen Recep LNCaP Cell Luteinizing Hormone Release Hormone Human Androgen Receptor Amino Terminal Domain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andrews, P. E., C. Y. Young, B. T. Montgomery, and D. J. Tindall. 1992. Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer Res. 52: 1525–1529.PubMedGoogle Scholar
  2. 2.
    Berman, D. M. and D. W. Russell. 1993. Cell-type-specific expression of rat steroid 5 alphareductase isozymes. Proc. Natl. Acad. Sci. USA 90: 9359–9363.PubMedCrossRefGoogle Scholar
  3. 3.
    Berrevoets, C. A., P. Doesburg, K. Steketee, J. Trapman, and A. O. Brinkmann. 1998. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol. Endocrinol. 12: 1172–1183.PubMedCrossRefGoogle Scholar
  4. 4.
    Blok, L. J., M. E. Grossmann, J. E. Perry, and D. J. Tindall. 1995. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol. Endocrinol. 9: 1610–1620.PubMedCrossRefGoogle Scholar
  5. 5.
    Blok, L. J., P. E. de Ruiter, and A. O. Brinkmann. 1998. Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry 37: 3850–3857.PubMedCrossRefGoogle Scholar
  6. 6.
    Brady, M. E., D. M. Ozanne, L. Gaughan, I. Waite, S. Cook, D. E. Neal, et al. 1999. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274: 17,599–17, 604.Google Scholar
  7. 7.
    Brinkmann, A. O., L. J. Blok, P. E. de Ruiter, P. Doesburg, K. Steketee, C. A. Berrevoets, et al. 1999. Mechanisms of androgen receptor activation and function. J. Steroid Biochem. Mol. Biol. 69: 307–313.PubMedCrossRefGoogle Scholar
  8. 8.
    Brown, C. J., S. J. Goss, D. B. Lubahn, D. R. Joseph, E. M. Wilson, F. S. French, et al. 1989. Androgen receptor locus on the human X chromosome: regional localization to Xql 1–12 and description of a DNA polymorphism. Am. J. Hum. Genet. 44: 264–269.PubMedGoogle Scholar
  9. 9.
    Bruchovsky, N. and J. D. Wilson 1968. The conversion of testosterone to 5-alphaandrostan-l7-beta-ol-3-one by rat prostate in vivo and in vitro. J. Biol. Chem. 243: 2012–2021.PubMedGoogle Scholar
  10. 10.
    Bruchovsky, N., P. S. Rennie, and A. Vanson. 1975. Studies on the regulation of the concentration of androgens and androgen receptors in nuclei of prostatic cells. Biochim. Biophys. Acta 394: 248–266.PubMedCrossRefGoogle Scholar
  11. 11.
    Burgess, L. H. and R. J. Handa. 1993. Hormonal regulation of androgen receptor mRNA in the brain and anterior pituitary gland of the male rat. Mol. Brain Res. 19: 31–38.PubMedCrossRefGoogle Scholar
  12. 12.
    Carraway, K. L. 3rd and S. J. Burden. 1995. Neuregulins and their receptors. Curr. Opinion Neurobiol. 5: 606–612.CrossRefGoogle Scholar
  13. 13.
    Chamberlain, N. L., E. D. Driver, and R. L. Miesfeld. 1994. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect trans-activation function. Nucleic Acids Res. 22: 3181–3186.PubMedCrossRefGoogle Scholar
  14. 14.
    Chan, J. M., M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma, P. Wilkinson, et al. 1998. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563–566.PubMedCrossRefGoogle Scholar
  15. 15.
    Chang, C. H., D. R. Rowley, and D. J. Tindall. 1983. Purification and characterization of the androgen receptor from rat ventral prostate. Biochemistry 22: 6170–6175.PubMedCrossRefGoogle Scholar
  16. 16.
    Chang, C. H., D. R. Rowley, T. J. Lobl, and D. J. Tindall. 1982. Purification and characterization of androgen receptor from steer seminal vesicle. Biochemistry 21: 4102–4109.PubMedCrossRefGoogle Scholar
  17. 17.
    Chang, C. S., J. Kokontis, and S. T. Liao. 1988. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240: 324–326.PubMedCrossRefGoogle Scholar
  18. 18.
    Chen, S., P. C. Supakar, R. L. Vellanoweth, C. S. Song, B. Chatterjee, and A. K. Roy. 1997. Functional role of a conformationally flexible homopurine/homopyrimidine domainGoogle Scholar
  19. of the androgen receptor gene promoter interacting with Sp 1 and a pyrimidine single strand DNA-binding protein. Mol. Endocrinol. 11: 3–15.Google Scholar
  20. 19.
    Chung, T. D., J. J. Yu, M. T. Spiotto, M. Bartkowski, and J. W. Simons. 1999. Characterization of the role of IL-6 in the progression of prostate cancer. Prostate 38: 199–207.PubMedCrossRefGoogle Scholar
  21. 20.
    Craft, N., Y. Shostak, M. Carey, and C. L. Sawyers. 1999. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med. 5: 280–285.PubMedCrossRefGoogle Scholar
  22. 21.
    Cude, K. J., S. C. Dixon, Y. Guo, J. Lisella, and W. D. Figg. 1999. The androgen receptor: genetic considerations in the development and treatment of prostate cancer. J. Mol. Med. 77: 419–426.Google Scholar
  23. 22.
    Culig, Z., A. Hobisch, A. Hittmair, M. V. Cronauer, C. Radmayr, J. Zhang, et al. 1997. Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells. Prostate 32: 106–114.PubMedCrossRefGoogle Scholar
  24. 23.
    Culig, Z., A. Hobisch, M. V. Cronauer, C. Radmayr, A. Hittmair, J. Zhang, et al. 1996. Regulation of prostatic growth and function by peptide growth factors. Prostate 28: 392–405.Google Scholar
  25. 24.
    Culig, Z., A. Hobisch, M. V. Cronauer, C. Radmayr, J. Trapman, A. Hittmair, et al. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54: 5474–5478.PubMedGoogle Scholar
  26. 25.
    Culig, Z., A. Hobisch, M. V. Cronauer, A. C. Cato, A. Hittmair, C. Radmayr, et al. 1993. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol. Endocrinol. 7: 1541–1550.PubMedCrossRefGoogle Scholar
  27. 26.
    Culig, Z., J. Stober, A. Gast, H. Peterziel, A. Hobisch, C. Radmayr, et al. 1996. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone. Cancer Detect. Prey. 20: 68–75.Google Scholar
  28. 27.
    Dai, J. L. and K. L. Burnstein. 1996. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Mol. Endocrinol. 10: 1582–1594.PubMedCrossRefGoogle Scholar
  29. 28.
    Danzo, B. J., S. N. Pavlou, and H. L. Anthony. 1990. Hormonal regulation of androgen-binding protein in the rat. Endocrinology 127: 2829–2838.PubMedCrossRefGoogle Scholar
  30. 29.
    Darne, C., G. Veyssiere, and C. Jean. 1998. Phorbol ester causes ligand independent activation of the androgen receptor. Eur. J. Biochem. 256: 541–549.PubMedCrossRefGoogle Scholar
  31. 30.
    de Boer, W., M. Lindh, J. Bolt, A. Brinkmann, and E. Mulder. 1986. Characterization of the calf uterine androgen receptor and its activation to the deoxyribonucleic acid-binding state. Endocrinology 118: 851–861.PubMedCrossRefGoogle Scholar
  32. 31.
    de Ruiter, P. E., R. Teuwen, J. Trapman, R. Dijkema, and A. O. Brinkmann. 1995. Synergism between androgens and protein kinase-C on androgen-regulated gene expression. Mol. Cell. Endocrinol. 110: R1–6.Google Scholar
  33. 32.
    Desterro, J. M., J. Thomson, and R. T. Hay. 1997. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417: 297–300.PubMedCrossRefGoogle Scholar
  34. 33.
    Ding, V. D., D. E. Moller, W. P. Feeney, V. Didolkar, A. M. Nakhla, L. Rhodes, et al. 1998. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway. Endocrinology 139: 213–218.PubMedCrossRefGoogle Scholar
  35. 34.
    Ding, X. F., C. M. Anderson, H. Ma, H. Hong, R. M. Uht, P. J. Kushner, et al. 1998. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12: 302–313.Google Scholar
  36. 35.
    Doesburg, P. C. W. Kuil, C. A. Berrevoets, K. Steketee, P. W. Faber, E. Mulder, et al. 1997. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36: 1052–1064.Google Scholar
  37. 36.
    Edwards, D. P. 1999. Coregulatory proteins in nuclear hormone receptor action. Vitam. Horm. 55: 165–218.PubMedCrossRefGoogle Scholar
  38. 37.
    Fang, Y., A. E. Fliss, D. M. Robins, and A. J. Caplan. 1996. Hsp90 regulates androgen receptor hormone binding affinity in vivo. J. Biol. Chem. 271: 28,697–28, 702.Google Scholar
  39. Froesch, B. A., S. Takayama, and J. C. Reed. 1998. BAG-1L protein enhances androgen receptor function. J. Biol. Chem. 273: 11,660–11,666.Google Scholar
  40. 39.
    Fujimoto, N., S. Yeh, H. Y. Kang, S. Inui, H. C. Chang, A. Mizokami, et al. 1999. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 274: 8316–8321.PubMedCrossRefGoogle Scholar
  41. 40.
    Furr, B. J. 1995. Casodex: preclinical studies and controversies. Ann. NY Acad. Sci. 761: 79–96.Google Scholar
  42. 41.
    Giovannucci, E., M. J. Stampfer, K. Krithivas, M. Brown, D. Dahl, A. Brufsky, et al. 1997. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA 94: 3320–3323 (published erratum appears in Proc. Natl. Acad. Sci. USA 94: 8272, 1997 ).CrossRefGoogle Scholar
  43. 42.
    Gloyna, R. E., P. K. Siiteri, and J. D. Wilson. 1970. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J. Clin. Investig. 49: 1746–1753.Google Scholar
  44. 43.
    Gordon, D. A., N. L. Chamberlain, F. A. Flomerfelt, and R. L. Miesfeld. 1995. A cell-specific and selective effect on transactivation by the androgen receptor. Exp. Cell Res. 217: 368–377.Google Scholar
  45. 44.
    Gregory, C. W., K. G. Hamil, D. Kim, S. H. Hall, T. G. Pretlow, J. L. Mohler, et al. 1998. Androgen receptor expression in androgen independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res. 58: 5718–5724.Google Scholar
  46. 45.
    Gurpide, E. 1978. Enzymatic modulation of hormonal action at the target tissue. J. Toxicol. Envir. Health 4: 249–268.CrossRefGoogle Scholar
  47. 46.
    Ham, J., A. Thomson, M. Needham, P. Webb, and M. Parker. 1988. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res. 16: 5263–5276.PubMedCrossRefGoogle Scholar
  48. 47.
    Hammond, G. L. 1990. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocr. Rev. 11: 65–79.PubMedCrossRefGoogle Scholar
  49. 48.
    Hard, T., E. Kellenbach, R. Boelens, B. A. Maler, K. Dahlman, L. P. Freedman, et al. 1990. Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249: 157–160.PubMedCrossRefGoogle Scholar
  50. 49.
    Hard, T., E. Kellenbach, R. Boelens, R. Kaptein, K. Dahlman, J. Carlstedt-Duke, et al. 1990. 1H NMR studies of the glucocorticoid receptor DNA-binding domain: sequential assignments and identification of secondary structure elements. Biochemistry 29: 9015–9023.Google Scholar
  51. 50.
    Heinlein, C. A., H. Ting, S. Yeh, and C. Chang. 1999. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor. J. Biol. Chem. 274: 16,147–16, 152.Google Scholar
  52. 51.
    Henttu, P. and P. Vihko. 1992. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line. J. Steroid Biochem. Mol. Biol. 41: 349–360.PubMedCrossRefGoogle Scholar
  53. 52.
    Henttu, P. and P. Vihko. 1993. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res. 53: 1051–1058.PubMedGoogle Scholar
  54. 53.
    Hiipakka, R. A. and S. Liao. 1988. Steroid receptor recycling and interaction of receptor with RNA. Am. J. Clin. Oncol. 11 (Suppl. 2): S18–22.PubMedCrossRefGoogle Scholar
  55. 54.
    Hobisch, A., I. E. Eder, T. Putz, W. Horninger, G. Bartsch, H. Klocker, et al. 1998. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 58: 4640–4645.PubMedGoogle Scholar
  56. 55.
    Husmann, D. A., C. M. Wilson, M. J. McPhaul, W. D. Tilley, and J. D. Wilson. 1990. Antipeptide antibodies to two distinct regions of the androgen receptor localize the recep-Google Scholar
  57. tor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 126: 2359–2368.Google Scholar
  58. 56.
    Izbicka, E., J. R. Macdonald, K. Davidson, R. A. Lawrence, L. Gomez, and D. D. Hoff. 1999. 5,6 Dihydro-5’-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells. Anticancer Res. 19: 1285–1292.Google Scholar
  59. 57.
    Jenster, G., H. A. van der Korput, C. van Vroonhoven, T. H. van der Kwast, J. Trapman, and A. O. Brinkmann. 1991. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol. 5: 1396–1404.PubMedCrossRefGoogle Scholar
  60. 58.
    Jenster, G., H. A. van der Korput, J. Trapman, and A. O. Brinkmann. 1995. Identification of two transcriptional activation units in the N-terminal domain of the human androgen receptor. J. Biol. Chem. 270: 7341–7346.PubMedCrossRefGoogle Scholar
  61. 59.
    Jenster, G., J. Trapman, and A. O. Brinkmann. 1993. Nuclear import of the human androgen receptor. Biochem. J. 293: 761–768.PubMedGoogle Scholar
  62. 60.
    Johnson, M. P., C. Y. Young, D. R. Rowley, and D. J. Tindall. 1987. A common molecular weight of the androgen receptor monomer in different target tissues. Biochemistry 26: 3174–3182.PubMedCrossRefGoogle Scholar
  63. 61.
    Kallio, P. J., H. Poukka, A. Moilanen, O. A. Janne, and J. J. Palvimo. 1995. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol. Endocrinol. 9: 1017–1028.PubMedCrossRefGoogle Scholar
  64. 62.
    Kallio, P. J., O. A. Janne, and J. J. Palvimo. 1994. Agonists, but not antagonists, alter the conformation of the hormone-binding domain of androgen receptor. Endocrinology 134: 998–1001.PubMedCrossRefGoogle Scholar
  65. 63.
    Kang, H. Y., S. Yeh, N. Fujimoto, and C. Chang. 1999. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem. 274: 8570–8576.PubMedCrossRefGoogle Scholar
  66. 64.
    Kasper, S., P. S. Rennie, N. Bruchovsky, P. C. Sheppard, H. Cheng, L. Lin, et al. 1994. Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J. Biol. Chem. 269: 31,763–31, 769.Google Scholar
  67. 65.
    Kemppainen, J. A. and E. M. Wilson. 1996. Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization. Urology 48: 157–163.PubMedCrossRefGoogle Scholar
  68. 66.
    Kemppainen, J. A., E. Langley, C. I. Wong, K. Bobseine, W. R. Kelce, and E. M. Wilson. 1999. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol. Endocrinol. 13: 440 /154.Google Scholar
  69. 67.
    Kemppainen, J. A., M. V. Lane, M. Sar, and E. M. Wilson. 1992. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 267: 968–974.PubMedGoogle Scholar
  70. 68.
    Knudsen, K. E., W. K. Cavenee, and K. C. Arden. 1999. D-Type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res. 59: 2297–2301.PubMedGoogle Scholar
  71. 69.
    Kokontis, J. M. and S. Liao. 1999. Molecular action of androgen in the normal and neo-plastic prostate. Vitam. Horm. 55: 219–307.PubMedCrossRefGoogle Scholar
  72. 70.
    Kolvenbag, G. J., G. R. Blackledge, and K. Gotting-Smith. 1998. Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development. Prostate 34: 61–72.PubMedCrossRefGoogle Scholar
  73. 71.
    Kopp, H., J. R. W. Masters, W. Wieland, F. Hofstaedter, and R. Buettner. 1993. Differentielle Regulation des Androgenrezeptor-Promoters in hormonsensitiven und-resistenten Prostatakarzinomzellen. [Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells]. [German] Verhandlungen der Deutschen Gesellschaft fur Pathologie 77: 129–132.Google Scholar
  74. 72.
    Krithivas, K., S. M. Yurgalevitch, B. A. Mohr, C. J. Wilcox, S. J. Batter, M. Brown, et al. 1999. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J. Endocrinol. 162: 137–142.PubMedCrossRefGoogle Scholar
  75. 73.
    Krongrad, A.., C. M. Wilson, J. D. Wilson, D. R. Allman, and M. J. McPhaul. 1991. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol. Cellular Endocrinol. 76: 79–88.CrossRefGoogle Scholar
  76. 74.
    Kuil, C. W. and E. Mulder. 1994. Mechanism of antiandrogen action: conformational changes of the receptor. Mol. Cell. Endocrinol. 102: R1–5.PubMedCrossRefGoogle Scholar
  77. 75.
    Kuiper, G. G., P. E. de Ruiter, and A. O. Brinkmann. 1992. Androgen receptor heterogeneity in LNCaP cells is caused by a hormone independent phosphorylation step. J. Steroid Biochem. Mol. Biol. 41: 697–700.PubMedCrossRefGoogle Scholar
  78. 76.
    Kuiper, G. G., P. E. de Ruiter, J. Trapman, W. J. Boersma, J. A. Grootegoed, and A. O. Brinkmann. 1993. Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochem. J. 291: 95–101.PubMedGoogle Scholar
  79. 77.
    Kuiper, G. G., P. W. Faber, H. C. van Rooij, J. A. van der Korput, C. Ris-Stalpers, P. Klaassen, et al. 1989. Structural organization of the human androgen receptor gene. J. Mol. Endocrinol. 2: R1–4.PubMedCrossRefGoogle Scholar
  80. 78.
    Kumar, M. V. and D. J. Tindall. 1998. Transcriptional regulation of the steroid receptor genes. Prog. Nucleic Acid Res. Mol. Biol. 59: 289–306.PubMedCrossRefGoogle Scholar
  81. 79.
    Kupfer, S. R., E. M. Wilson, and F. S. French. 1994. Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J. Biol. Chem. 269: 20,622–20, 628.Google Scholar
  82. 80.
    Kupfer, S. R., K. B. Marschke, E. M. Wilson, and F. S. French. 1993. Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J. Biol. Chem. 268: 17,519–17, 527.Google Scholar
  83. 81.
    Langley, E., J. A. Kemppainen, and E. M. Wilson. 1998. Intermolecular NH2-/carboxylterminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem. 273: 92–101.PubMedCrossRefGoogle Scholar
  84. 82.
    Langley, E., Z. X. Zhou, and E. M. Wilson. 1995. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270: 29,983–29, 990.Google Scholar
  85. 83.
    Lanz, R. B., N. J. McKenna, S. A. Onate, U. Albrecht, J. Wong, S. Y. Tsai, et al. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97: 17–27.PubMedCrossRefGoogle Scholar
  86. 84.
    Lasnitzki, I., H. R. Franklin, and J. D. Wilson. 1974. The mechanism of androgen uptake and concentration by rat ventral prostate in organ culture. J. Endocrinol. 60: 81–90.PubMedCrossRefGoogle Scholar
  87. 85.
    Lesser, B. and N. Bruchovsky. 1973. The effects of testosterone, 5 dihydrotestosterone and adenosine 3’, 5’ monophosphate on cell proliferation and differentiation on rat prostate. Biochim. Biophys. Acta 308: 426–437.PubMedCrossRefGoogle Scholar
  88. 86.
    Limonta, P., D. Dondi, R. M. Moretti, R. Maggi, and M. Motta. 1992. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP. J. Clin. Endocrinol. Metabol. 75: 207–212.CrossRefGoogle Scholar
  89. 87.
    Limonta, P., R. M. Moretti, D. Dondi, M. M. Marelli, and M. Motta. 1994. Androgen dependent prostatic tumors: biosynthesis and possible actions of LHRH. J. Steroid Biochem. Mol. Biol. 49: 347–350.PubMedCrossRefGoogle Scholar
  90. 88.
    Lin, D. L. and E. T. Keller. 1999. Mechanism of interleukin-6 promotion of androgen receptor function in prostate cancer cells. Proceedings of the International Prostate Cancer Meeting, Iowa City, IA.Google Scholar
  91. 89.
    Lindzey, J., M. V. Kumar, M. Grossman, C. Young, and D. J. Tindall. 1994. Molecular mechanisms of androgen action. Vitam. Horm. 49: 383–432.PubMedCrossRefGoogle Scholar
  92. 90.
    Lu, S., S. Y. Tsai, and M. J. Tsai. 1997. Regulation of androgen dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 57: 4511–4516.PubMedGoogle Scholar
  93. 91.
    Lubahn, D. B., D. R. Joseph, M. Sar, J. Tan, H. N. Higgs, R. E. Larson, et al. 1988. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol. Endocrinol. 2: 1265–1275.PubMedCrossRefGoogle Scholar
  94. 92.
    Lubahn, D. B., D. R. Joseph, P. M. Sullivan, H. F. Willard, F. S. French, and E. M. Wilson. 1988. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240: 327–330.PubMedCrossRefGoogle Scholar
  95. 93.
    Luisi, B. F., W. X. Xu, Z. Otwinowski, L. P. Freedman, K. R. Yamamoto, and P. B. Sigler. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Science 352: 497–505.Google Scholar
  96. 94.
    Marivoet, S., P. Van Dijck, G. Verhoeven, and W. Heyns. 1992. Interaction of the 90-kDa heat shock protein with native and in vitro translated androgen receptor and receptor fragments. Mol. Cell. Endocrinol. 88: 165–174.PubMedCrossRefGoogle Scholar
  97. 95.
    Miyamoto, H., S. Yeh, G. Wilding, and C. Chang. 1998. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DÚ145 cells. Proc. Natl. Acad. Sci. USA 95: 7379–7384.PubMedCrossRefGoogle Scholar
  98. 96.
    Moilanen, A. M., H. Poukka, U. Karvone, M. Hakli, O. A. Janne, and J. J. Palvimo. 1998. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol. Cell. Biol. 18: 5128–5139.PubMedGoogle Scholar
  99. 97.
    Moilanen, A. M., U. Karvonen, H. Poukka, O. A. Janne, et al. 1998. Activation of androgen receptor function by a novel nuclear protein kinase. Mol. Biol. Cell 9: 2527–2543.PubMedGoogle Scholar
  100. 98.
    Moilanen, A. M., U. Karvonen, H. Poukka, W. Yan, J. Toppari, O. A. Janne, and J. J. Palvimo. 1999. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J. Biol. Chem. 274: 3700–3704.PubMedCrossRefGoogle Scholar
  101. 99.
    Mora, G. R. and V. B. Mahesh. 1999. Autoregulation of the androgen receptor at the translational level: testosterone induced accumulation of the ARmRNA in the rat ventral prostate polyribosomes. Steroids 64: 587–591.PubMedCrossRefGoogle Scholar
  102. 100.
    Mora, G. R., G. S. Prins, and V. B. Mahesh. 1996. Autoregulation of androgen receptor protein and messenger RNA in rat ventral prostate is protein synthesis dependent. J. Steroid Biochem. Mol. Biol. 58: 539–549.PubMedCrossRefGoogle Scholar
  103. 101.
    Moretti, R. M., M. M. Marelli, D. Dondi, A. Poletti, L. Martini, M. Motta, et al. 1996. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145. J. Clin. Endocrinol. Metabol. 81: 3930–3937.CrossRefGoogle Scholar
  104. 102.
    Mori, S., K. Murakami-Mori, and B. Bonavida. 1999. Interleukin-6 induces G1 arrest through induction of p27(Kip 1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem. Biophys. Res. Commun. 257: 609–614.PubMedCrossRefGoogle Scholar
  105. 103.
    Murthy, L. R., M. P. Johnson, D. R. Rowley, C. Y. Young, P. T. Scardino, and D. J. Tindall. 1986. Characterization of steroid receptors in human prostate using mibolerone. Prostate 8: 241–253.PubMedCrossRefGoogle Scholar
  106. 104.
    Nazareth, L. V. and N. L. Weigel. 1996. Activation of the human androgen receptor through a protein kinase A signaling pathway. J. Biol. Chem. 271: 19,900–19, 907.Google Scholar
  107. 105.
    Nemoto, T., Y. Ohara-Nemoto, and M. Ota. 1992. Association of the 90-kDa heat shock protein does not affect the ligand-binding ability of androgen receptor. J. Steroid Biochem. Mol. Biol. 42: 803–812.PubMedCrossRefGoogle Scholar
  108. 106.
    Neuman, E., M. H. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzo, et al. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17: 5338–5347.PubMedGoogle Scholar
  109. 107.
    Ohara-Nemoto, Y., T. Nemoto, and M. Ota. 1988. Ribonucleic acid association with androgen receptor from rat submandibular gland. J. Steroid Biochem. 29: 27–31.PubMedCrossRefGoogle Scholar
  110. 108.
    Okamoto, M., C. Lee, and R. Oyasu. 1997. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res. 57: 141–146.PubMedGoogle Scholar
  111. 109.
    Peterziel, H., Z. Culig, J. Stober, A. Hobisch, C. Radmayr, G. Bartsch, et al. 1995. Mutant androgen receptors in prostatic tumors distinguish between amino acid-sequence requirements for transactivation and ligand binding. Int. J. Cancer 63: 544–550.PubMedCrossRefGoogle Scholar
  112. 110.
    Porto, C. S., M. F. Lazari, L. C. Abreu, C. W. Bardin, and G. L. Gunsalus. 1995. Receptors for androgen-binding proteins: internalization and intracellular signalling. J. Steroid Biochem. Mol. Biol. 53: 561–565.PubMedCrossRefGoogle Scholar
  113. 111.
    Poukka, H., P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne. 1999. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274: 19,441–19, 446.Google Scholar
  114. 112.
    Prescott, J. L., L. Blok, and D. J. Tindall. 1998. Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 35: 71–80.PubMedCrossRefGoogle Scholar
  115. 113.
    Qiu, Y., L. Ravi, and H. J. Kung. 1998. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393: 83–85.PubMedCrossRefGoogle Scholar
  116. 114.
    Quarmby, V. E., W. G. Yarbrough, D. B. Lubahn, F. S. French, and E. M. Wilson. 1990. Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol. Endocrinol. 4: 22–28.PubMedCrossRefGoogle Scholar
  117. 115.
    Rana, S., D. Bisht, and P. K. Chakraborti. 1999. Synergistic activation of yeast-expressed rat androgen receptor by modulators of protein kinase-A. J. Mol. Biol. 286: 669–681.PubMedCrossRefGoogle Scholar
  118. 116.
    Reese, D. M. and E. J. Small. 1999. Secondary hormonal manipulations in hormone refractory prostate cancer. Urol. Clin. N. Am. 26: 311–321.CrossRefGoogle Scholar
  119. 117.
    Robel, P., B. Eychenne, J. P. Blondeau, I. Jung-Testas, M. T. Groyer, C. Mercier-Bodard, et al. 1983. Androgen receptors in rat and human prostate. Horm. Res. 18: 28–36.PubMedCrossRefGoogle Scholar
  120. 118.
    Rosner, W. 1990. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocrine Rev. 11: 80–91.CrossRefGoogle Scholar
  121. 119.
    Rosner, W., D. J. Hryb, M. S. Khan, A. M. Nakhla, and N. A. Romas. 1998. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem. Mol. Biol. 69: 481–485.CrossRefGoogle Scholar
  122. 120.
    Rowley, D. R., R. T. Premont, M. P. Johnson, C. Y. Young, and D. J. Tindall. 1986. Properties of an intermediate-sized androgen receptor: association with RNA. Biochemistry 25: 6988–6995.PubMedCrossRefGoogle Scholar
  123. 121.
    Roy, A. K., Y. Lavrovsky, C. S. Song, S. Chen, M. H. Jung, N. K. Velu, et al. 1999. Regulation of androgen action. Vitam. Horm. 55: 309–352.PubMedCrossRefGoogle Scholar
  124. 122.
    Russell, D. W., D. M. Berman, J. T. Bryant, K. M. Cala, D. L. Davis, C. P. Landrum, et al. 1994. The molecular genetics of steroid 5 alpha-reductases. Recent Prog. Horm. Res. 49: 275–284.PubMedGoogle Scholar
  125. 123.
    Sartor, O., Q. Zheng, and J. A. Eastham. 1999. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 53: 378–380.PubMedCrossRefGoogle Scholar
  126. 124.
    Schwabe, J. W., D. Neuhaus, and D. Rhodes. 1990. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348: 458–461.PubMedCrossRefGoogle Scholar
  127. 125.
    Shan, L. X., M. C. Rodriguez, and O. A. Janne. 1990. Regulation of androgen receptor protein and mRNA concentrations by androgens in rat ventral prostate and seminal vesicles and in human hepatoma cells. Mol. Endocrinol. 4: 1636–1646.PubMedCrossRefGoogle Scholar
  128. 126.
    Shibata, H., T. E. Spencer, S. A. Onate, G. Jenster, S. Y. Tsai, M. J. Tsai, et al. 1997. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52: 141–164 (discussion 164, 165 ).Google Scholar
  129. 127.
    Siiteri, P. K. and J. D. Wilson. 1970. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J. Clin. Investig. 49: 1737–1745.PubMedCrossRefGoogle Scholar
  130. 128.
    Simental, J. A., M. Sar, M. V. Lane, F. S. French, and E. M. Wilson. 1991. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266: 510–518.PubMedGoogle Scholar
  131. 129.
    Spencer, J. A., J. M. Watson, D. B. Lubahn, D. R. Joseph, F. S. French, E. M. Wilson, et al. 1991. The androgen receptor gene is located on a highly conserved region of the X chromosomes of marsupial and monotreme as well as eutherian mammals. J. Hered. 82: 134–139.PubMedGoogle Scholar
  132. 130.
    Steinsapir, J., G. Mora, and T. G. Muldoon. 1991. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor. Biochim. Biophys. Acta 1094: 103–112.PubMedCrossRefGoogle Scholar
  133. 131.
    Strott, C. A. 1996. Steroid sulfotransferases. Endocrine Rev. 17: 670–697.Google Scholar
  134. 132.
    Tan, J. A., D. R. Joseph, V. E. Quarmby, D. B. Lubahn, M. Sar, F. S. French, et al. 1988. The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol. Endocrinol. 2: 1276–1285.PubMedCrossRefGoogle Scholar
  135. 133.
    Teutsch, G., F. Goubet, T. Battmann, A. Bonfils, F. Bouchoux, E. Cerede, et al. 1994. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. J. Steroid Biochem. Mol. Biol. 48: 111–119.PubMedCrossRefGoogle Scholar
  136. 134.
    Tilley, W. D., M. Marcelli, and M. J. McPhaul. 1990. Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J. Biol. Chem. 265: 13,776–13, 781.Google Scholar
  137. 135.
    Tsai, M. J. and B. W. O’Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451–486.PubMedCrossRefGoogle Scholar
  138. 136.
    Veldscholte, J., C. A. Berrevoets, C. Ris-Stalpers, G. G. Kuiper, G. Jenster, J. Trapman, et al. 1992. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to anti-androgens. J. Steroid Biochem. Mol. Biol. 41: 665–669.PubMedCrossRefGoogle Scholar
  139. 137.
    Veldscholte, J., C. Ris-Stalpers, G. G. Kuiper, G. Jenster, C. Berrevoets, E. Claassen, et al. 1990. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173: 534–540.PubMedCrossRefGoogle Scholar
  140. 138.
    Wang, L. G., X. M. Liu, W. Kreis, and D. R. Budman. 1999. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. Biochem. Biophys. Res. Commun. 259: 21–28.PubMedCrossRefGoogle Scholar
  141. 139.
    Ware, J. L. 1993. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 12: 287–301.PubMedCrossRefGoogle Scholar
  142. 140.
    Wilson, J. D. 1978. Sexual differentiation. Annu. Rev. Physiol. 40: 279–306.PubMedCrossRefGoogle Scholar
  143. 141.
    Wolf, D. A., T. Herzinger, H. Hermeking, D. Blaschke, and W. Horz. 1993. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol. Endocrinol. 7: 924–936.PubMedCrossRefGoogle Scholar
  144. 142.
    Yeh, S. and C. Chang. 1996. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93: 5517–5521.PubMedCrossRefGoogle Scholar
  145. 143.
    Yeh, S., H. K. Lin, H. Y. Kang, T. H. Thin, M. F. Lin, and C. Chang. 1999. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA 96: 5458–5463.PubMedCrossRefGoogle Scholar
  146. 144.
    Yeh, S., H. Miyamoto, and C. Chang. 1997. Hydroxyflutamide may not always be a pure antiandrogen (letter). Lancet 349: 852, 853.Google Scholar
  147. 145.
    Yeh, S., H. Miyamoto, K. Nishimura, H. Kang, J. Ludlow, P. Hsiao, et al. 1998. Retino-blastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Commun. 248: 361–367.PubMedCrossRefGoogle Scholar
  148. 146.
    Young, C. Y., P. E. Andrews, and D. J. Tindall. 1995. Expression and androgenic regulation of human prostate-specific kallikreins. J. Androl. 16: 97–99.PubMedGoogle Scholar
  149. 147.
    Zhou, Z. X., C. I. Wong, M. Sar, and E. M. Wilson. 1994. The androgen receptor: an overview. Recent Prog. Horm. Res. 49: 249–274.PubMedGoogle Scholar
  150. 148.
    Zhou, Z. X., M. V. Lane, J. A. Kemppainen, F. S. French, and E. M. Wilson. 1995. Specificity of ligand dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9: 208–218.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Gloria R. Mora
  • Donald J. Tindall

There are no affiliations available

Personalised recommendations